Dr. Pierre Maison-Blanche appointed as New Chief Medical Officer of Cardiabase

Feb. 18, 2013 - PRLog -- CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer.  

Dr. Maison-Blanche received his MD in 1981 and his board certification in Cardiology in 1986 from the University of Paris.  For the past 30 years, Dr. Maison-Blanche has been extensively involved in clinical cardiology and research as a staff member of the Cardiology Division, Lariboisière Hospital (Paris, France), a leading European academic center in this field of medicine.  He currently serves as a Cardiology Consultant for the Assistance Publique des Hôpitaux de Paris (France).

Dr. Maison-Blanche is an internationally recognized expert in non-invasive cardiac electrophysiology.  Among his many achievements, he organized the first ECG Laboratory at Lariboisière Hospital under the leadership of Philippe Coumel.  He has published extensively in leading international journals on electrocardiography, electrophysiology and cardiac arrhythmias.  He is a member of numerous professional societies and boards including the International Society for Holter and Noninvasive Electrocardiology.

Dr. Maison-Blanche has extensive experience in the scientific, clinical and regulatory aspects of electrocardiography in clinical trials.  In1998, he established the Centralized ECG Services Department for MDS Pharma Services in Paris (France) and chaired the MDS ECG Advisory Board from 2002 to 2006.  From 2006 to 2012, Dr. Maison-Blanche was appointed Chief Medical Officer of Bio Medical Systems (St. Louis, Missouri, USA).  He has participated in several meetings with the Food and Drug Administration (FDA) and serves as an adviser on ECG issues to many pharmaceutical companies.  He is currently a member or Chairman of several Data Monitoring Committees in ongoing clinical trials.

"I am extremely enthusiastic to announce that Dr. Maison-Blanche has joined our company," said Pascal Voiriot, MD, founder and President of CardiaBase. "Pierre's expertise in the field of electrocardiography and more generally clinical cardiology will strengthen our company's commitment to excellence and leadership in centralized diagnostic services around the world".

Dr. Maison-Blanche will be based in Paris (France) and provide consulting services on scientific and medical issues to our clients, with a special emphasis on: ECG, holter and cardiovascular safety assessment.

"In the constantly changing field of clinical research, having an expert of Pierre's caliber on our team is critical to help CardiaBase achieve the highest standards of excellence and ultimately ensure our clients bring innovative medicines to market faster" added Pascal Voiriot.

About Cardiabase:

Based in France, Cardiabase is a worldwide cardiac core lab specialized in data acquisition, processing, analysis, reporting and archival for digital and paper 12-Lead ECG, stress electrocardiograms, holter monitoring and ambulatory blood pressure monitoring since 1999.

As the result of ten years of continuous research and innovation in ECG data analysis techniques, Cardiabase is today a full-service global CRO (Clinical Research Organization).

With proven expertise in supporting global clinical trials for pharmaceutical companies and bringing more than 4 years of experience in event adjudication in major industry-sponsored clinical trials, Cardiabase has successfully coordinated management of thousands of outcome events.

Cardiabase also provides sponsors assistance in designing their cardiovascular safety assessment strategy and delivers quality assured data in strict agreement with each sponsor's specific requirements.

For more information about Cardiabase please contact Alexandre Durand-Salmon via email at alexandre.durand-salmon@cardiabase.com or connect to our website http://www.cardiabase.com